CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards
CSL's Broadmeadows facility has been recognised as the Overall Winner of the 2025 Facility of the Year Award by the International Society for Pharmaceutical Engineering (ISPE).
The facility blends Pharma 4.0 principles with sustainable design to transform plasma manufacturing, setting new standards in responsible innovation.
- Purpose-built to optimise the production of plasma-derived therapies
- Combines cutting-edge technologies with a pioneering hybrid manufacturing platform
- Treats conditions such as immunodeficiencies, neurological disorders, and burns
CSL's base fractionation facility in Broadmeadows, Australia has been recognised as the Overall Winner of the 2025 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical Engineering (ISPE).
Author's summary: CSL wins award for innovative facility.
More News
- Major Candy Company Files Chapter 11 Bankruptcy Amid Halloween Week Shock - CCE l ONLINE NEWS
- Importing beef is not the solution | GABEL
- As top LDS Church leaders age, they move closer to ‘the zone of dementia’
- In the room deciding to form the Global Anglican Communion - THE OTHER CHEEK
- OpenAI offers free ChatGPT Go for one year to all users in India | TechCrunch
- Benz Hui Dies At 76 from Cancer-Related Organ Failure
- Neck size could be a clue to heart health
- Football Continues Strong Season, Eyeing Fourth-Straight Little Three Title – The Wesleyan Argus
- Fraternity and hope strengthen relations between Catholics and Anglicans
- The Coming Dementia Crisis—and the Cost of Doing Nothing